Trial Profile
Pharmacokinetics of aliskiren/hydrochlorothiazide (300/25 mg/day) versus aliskiren (300 mg/day) + hydrochlorothiazide (25 mg/day) in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jul 2011
Price :
$35
*
At a glance
- Drugs Aliskiren/hydrochlorothiazide (Primary) ; Aliskiren; Hydrochlorothiazide
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors Novartis Pharma A.G.
- 25 Jul 2011 New trial record
- 09 Jun 2011 Results published in the Journal of Clinical Pharmacology.